Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Roche Products Limited
Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 12/03/2012
PIL Invirase 200mg hard capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/03/2012 and displayed until Current
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 11/01/2011 and displayed until 12/03/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to dosage and administration
Updated on 05/08/2010 and displayed until 11/01/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 01/04/2010 and displayed until 05/08/2010
Reasons for adding or updating:
  • Change to Further Information section
Updated on 25/03/2010 and displayed until 01/04/2010
Reasons for adding or updating:
  • Change to drug interactions
Updated on 09/04/2009 and displayed until 25/03/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 18/07/2008 and displayed until 09/04/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 05/11/2007 and displayed until 18/07/2008
Reasons for adding or updating:
  • Change to drug interactions
Updated on 08/06/2007 and displayed until 05/11/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 13/04/2007 and displayed until 08/06/2007
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 22/01/2007 and displayed until 13/04/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 16/01/2007 and displayed until 22/01/2007
Reasons for adding or updating:
  • Change to Further Information section
Updated on 05/12/2006 and displayed until 16/01/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 01/11/2006 and displayed until 05/12/2006
Reasons for adding or updating:
  • Change to drug interactions
  • Change to date of revision
Updated on 31/10/2006 and displayed until 01/11/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 31/10/2006 and displayed until 31/10/2006
Reasons for adding or updating:
  • Change to drug interactions
Updated on 16/01/2006 and displayed until 31/10/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change from BAN to rINN
Updated on 12/09/2005 and displayed until 16/01/2006
Reasons for adding or updating:
  • Change to drug interactions
  • Change to date of revision
Updated on 07/07/2005 and displayed until 12/09/2005
Reasons for adding or updating:
  • Change of contra-indications
Updated on 10/02/2005 and displayed until 07/07/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 24/09/2004 and displayed until 10/02/2005
Reasons for adding or updating:
  • Change to drug interactions
  • Change to Further Information section
Updated on 20/04/2004 and displayed until 24/09/2004
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Further Information section
Updated on 18/11/2003 and displayed until 20/04/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 11/12/2003 and displayed until 18/11/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 11/11/2002 and displayed until 11/12/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 19/04/2002 and displayed until 11/11/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 14/02/2001 and displayed until 19/04/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  saquinavir mesilate